These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Blood loss and use of blood products in cases of cesarean hysterectomy for placenta accrete].
    Author: Solórzano-Vázquez JF, Hernández-Higareda S, Segura-Zavala JM, OsegueraTorres LF, De la Rosa-Hernández SS.
    Journal: Ginecol Obstet Mex; 2016 Aug; 84(8):491-7. PubMed ID: 29424510.
    Abstract:
    BACKGROUND: Placenta accreta (abnormal insertion of the placenta or part of the myometrium ) endangers the lives of pregnant women. It is a public health problem because it can be complicated by obstetric hemorrhage , the latter being the main cause of maternal death worldwide. OBJETIVE: To estimate the blood loss and the use of blood products in patients who underwent cesarean – hysterectomy for placenta accreta. MATERIAL AND METHODS: A descriptive study was conducted in HGO UMAE CMNO IMSS in patients who underwent cesarean – hysterectomy for placenta accreta in a period of 4 years. RESULTS: 106 cases of placenta accreta were studied, 23% had a massive bleeding of > 3000 cc. Packed red blood cells were transfused in 68% of events, fresh frozen plasma in platelet concentrates 29% and 6%. The history of uterine curettage was observed in 64 % and cesarean section 1 or 2 occasions in 76 % of cases. CONCLUSION: An early detection of placenta accreta in patients with risk factors to avoid emergency surgery is desired. Being prepared with blood products and appropriate use is a cornerstone in the management of this condition. The average blood loss was determined in cases of accreta in cesarean hysterectomy was 2523 milliliters.
    [Abstract] [Full Text] [Related] [New Search]